Despite a stock price increase, the company's financial indi...

Moomoo AI Feb 10, 2024 06:59

Despite a stock price increase, the company's financial indicators are worrisome. Low ROE, flat earnings growth, and a high payout ratio suggest minimal earnings growth. The company's performance disappoints due to low ROE and lack of reinvestment, resulting in poor earnings growth.

Liaoning Chengda Biotechnology Co.,Ltd.'s (SHSE:688739) On An Uptrend But Financial Prospects Look Pretty Weak: Is The Stock Overpriced?

Disclaimer: The above information does not represent the views of Moomoo Technologies Inc. (MTI) or constitute investment advice related to MTI and its affiliates. Read more

Translate

Report

1023 Views

Comment

Moomoo AI

Moomoo AI Official Account

Your AI assistant for discovering investment opportunities.

4730

Followers

Following

10K

Visitors